CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash (used in) provided by operating activities
Net (loss) income	$ (19,920)	$ 172
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Amortization of intangible assets	2,290	2,729
Depreciation	3,922	3,875
Change in value of warrants	0	1,352
Stock-based compensation expense	482	1,101
Amortization of financing fees	1,102	545
Deferred income taxes	(265)	(30)
Loss on extinguishment of debt	497	0
Other adjustments, net	(260)	193
Changes in operating assets and liabilities:
Accounts receivable, net	52,083	9,213
Inventory, net	(20,842)	(9,613)
Prepaid expenses and other assets	(5,362)	6,897
Accounts payable	(30,482)	379
Accrued expenses	16,572	6,262
Other noncurrent liabilities	(2,100)	(3,953)
Net cash (used in) provided by operating activities	(2,283)	19,122
Cash used in investing activities
Capital expenditures	(1,991)	(2,048)
Proceeds from corporate-owned life insurance	930	0
Other investing activities, net	7	13
Net cash used in investing activities	(1,054)	(2,035)
Cash provided by (used in) financing activities
Repayments of long-term debt and lease liabilities	(55,200)	(136)
Proceeds from revolving line of credit	180,298	394,631
Repayments of revolving line of credit	(89,826)	(412,488)
Payments of deferred financing costs	(1,970)	(375)
Proceeds from Weichai Warrant exercise	0	1,616
Other financing activities, net	58	(388)
Net cash provided by (used in) financing activities	33,360	(17,140)
Net increase (decrease) in cash, cash equivalents, and restricted cash	30,023	(53)
Cash, cash equivalents, and restricted cash at beginning of the period	3	54
Cash, cash equivalents, and restricted cash at end of the period	30,026	1
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets
Total cash, cash equivalents, and restricted cash	$ 30,026	$ 1